Bank of Montreal Can raised its holdings in shares of Natus Medical Inc (NASDAQ:BABY) by 11.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,206 shares of the medical equipment provider’s stock after buying an additional 4,615 shares during the period. Bank of Montreal Can’s holdings in Natus Medical were worth $1,728,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Eqis Capital Management Inc. boosted its holdings in Natus Medical by 25.0% during the third quarter. Eqis Capital Management Inc. now owns 16,740 shares of the medical equipment provider’s stock worth $628,000 after buying an additional 3,353 shares in the last quarter. Capital Management Associates NY bought a new stake in Natus Medical during the third quarter worth approximately $412,000. JPMorgan Chase & Co. boosted its holdings in Natus Medical by 13.4% during the third quarter. JPMorgan Chase & Co. now owns 37,767 shares of the medical equipment provider’s stock worth $1,411,000 after buying an additional 4,457 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Natus Medical by 24.7% during the third quarter. Wells Fargo & Company MN now owns 99,741 shares of the medical equipment provider’s stock worth $3,740,000 after buying an additional 19,726 shares in the last quarter. Finally, Eagle Asset Management Inc. boosted its holdings in Natus Medical by 18.8% during the third quarter. Eagle Asset Management Inc. now owns 499,376 shares of the medical equipment provider’s stock worth $19,076,000 after buying an additional 79,170 shares in the last quarter. Hedge funds and other institutional investors own 99.64% of the company’s stock.

Natus Medical Inc (BABY) opened at $30.50 on Wednesday. Natus Medical Inc has a 52 week low of $28.00 and a 52 week high of $43.60. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.32 and a quick ratio of 2.54. The company has a market cap of $950.20, a P/E ratio of -49.19 and a beta of 0.56.

Natus Medical (NASDAQ:BABY) last posted its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $0.42 EPS for the quarter, missing analysts’ consensus estimates of $0.54 by ($0.12). Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. The firm had revenue of $131.40 million during the quarter, compared to analyst estimates of $131.38 million. During the same period in the prior year, the business posted $0.51 EPS. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. analysts forecast that Natus Medical Inc will post 1.63 earnings per share for the current fiscal year.

A number of analysts recently weighed in on the stock. Benchmark restated a “buy” rating and set a $49.00 target price (down from $55.00) on shares of Natus Medical in a report on Tuesday, January 16th. BidaskClub cut shares of Natus Medical from a “sell” rating to a “strong sell” rating in a report on Saturday, January 6th. William Blair cut shares of Natus Medical from an “outperform” rating to a “market perform” rating in a report on Monday, January 8th. Finally, Zacks Investment Research cut shares of Natus Medical from a “buy” rating to a “hold” rating in a report on Tuesday, December 26th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $47.00.

COPYRIGHT VIOLATION NOTICE: “Bank of Montreal Can Raises Position in Natus Medical Inc (BABY)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/14/bank-of-montreal-can-raises-position-in-natus-medical-inc-baby.html.

Natus Medical Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Inc (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.